Vol 54, No 6 (2023)
Review article
Published online: 2023-11-07
Identifying frailty in older people living with diffuse large B-cell lymphoma: a systematic review
123
, 45
, 45
DOI: 10.5603/ahp.94456
Acta Haematol Pol 2023;54(6):382-388.
Abstract
Introduction: Diffuse large B-cell lymphoma (DLBCL) is a common neoplasm in older people; in this group, personalized therapies are important because whilst some patients are frailer, others are fitter. Yet, knowledge is lacking as to which frailty identification tools are most commonly used in older patients living with DLBCL. The objective of this systematic review was to address this knowledge gap. Material and methods: We searched PubMed, EMBASE, COCHRANE databases and Google Scholar for studies published before December 2022. We included studies conducted with DLBCL patients aged 60 years or older, where a frailty classification (fit, unfit, frail) had been reported in the context of prognostication and/or personalization of treatment. Results: Sixteen studies were included with a total number of 8,705 DLBCL patients (mean age 76 years, 54% men). Overall, 42% were classified as ‘frail’, and 40% as ‘fit’. The most frequent frailty identification method was Comprehensive Geriatric Assessment (CGA) (simplified: 75%, full: 13%), followed by the physical phenotype (6%) and the cumulative deficits index (6%) tools. The most common CGA domains utilized in the classification of frailty were the evaluation of basic activities of daily living (86%), instrumental activities of daily living (63%), comorbidities (81%), and geriatric syndromes (19%). Conclusion: Two in five DLBCL patients aged 60 years or older were classified as frail, and an almost equal proportion as fit, most commonly post-application of simplified CGA. More studies are required to validate specific frailty identification instruments in this population.
Keywords: frailtygeriatric oncologyComprehensive Geriatric Assessmentdiffuse large B cell lymphoma
References
- Hamaker ME, Te Molder M, Thielen N, et al. The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients — a systematic review. J Geriatr Oncol. 2018; 9(5): 430–440.
- Hamaker M, Lund C, Te Molder M, et al. Geriatric assessment in the management of older patients with cancer — a systematic review (update). J Geriatr Oncol. 2022; 13(6): 761–777.
- Ellis G, Whitehead MA, O'Neill D, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011(7): CD006211.
- Romero-Ortuno R, O'Shea D. Fitness and frailty: opposite ends of a challenging continuum! Will the end of age discrimination make frailty assessments an imperative? Age Ageing. 2013; 42(3): 279–280.
- Ferrat E, Paillaud E, Caillet P, et al. Performance of four frailty classifications in older patients with cancer: prospective elderly cancer patients cohort study. J Clin Oncol. 2017; 35(7): 766–777.
- O'Donovan A, Leech M. Personalised treatment for older adults with cancer: the role of frailty assessment. Tech Innov Patient Support Radiat Oncol. 2020; 16: 30–38.
- Solomon DH. Geriatric assessment: methods for clinical decision making. JAMA. 1988; 259(16): 2450–2452.
- Overcash J, Ford N, Kress E, et al. Comprehensive geriatric assessment as a versatile tool to enhance the care of the older person diagnosed with cancer. Geriatrics (Basel). 2019; 4(2).
- Romero-Ortuno R. Is phenotypical prefrailty all the same? Think again! https://www.bgs.org.uk/blog/is-phenotypical-prefrailty-all-the-same-think-again n.d. (30 Janueary, 2020).
- Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: A review. Eur J Intern Med. 2016; 31: 3–10.
- Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59(3): 255–263.
- Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M146–M156.
- Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173(5): 489–495.
- Searle SD, Mitnitski A, Gahbauer EA, et al. A standard procedure for creating a frailty index. BMC Geriatr. 2008; 8: 24.
- Aoki R, Karube K, Sugita Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006. Pathol Int. 2008; 58(3): 174–182.
- Tanaka T, Sakai R, Choi I, et al. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma. Sci Rep. 2022; 12(1): 3124.
- Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014; 32(24): 2595–2603.
- Morrison VA, Hamlin P, Soubeyran P, et al. Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary. Ann Oncol. 2015; 26(6): 1058–1068.
- Boyle HJ, Alibhai S, Decoster L, et al. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. Eur J Cancer. 2019; 116: 116–136.
- Soverini G, Tucci A. Clinical geriatric assessment in older patients with lymphoma: a narrative review. Ann Lymphoma. 2022; 6: 11–11.
- Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
- von Elm E, Altman DG, Egger M, et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014; 12(12): 1495–1499.
- Schulz KF, Altman DG, Moher D, et al. CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010; 8: 18.
- Spina M, Balzarotti M, Uziel L, et al. Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist. 2012; 17(6): 838–846.
- Merli F, Luminari S, Tucci A, et al. Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the fondazione italiana linfomi. J Clin Oncol. 2021; 39(11): 1214–1222.
- Olivieri A, Gini G, Bocci C, et al. Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. Oncologist. 2012; 17(5): 663–672.
- Merli F, Luminari S, Rossi G, et al. Fondazione Italiana Linfomi. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leuk Lymphoma. 2014; 55(1): 38–43.
- Bocci G, Pelliccia S, Orlandi P, et al. Remarkable remission rate and long-term efficacy of upfront metronomic chemotherapy in elderly and frail patients, with diffuse large b-cell lymphoma. J Clin Med. 2022; 11(23).
- Tucci A, Martelli M, Rigacci L, et al. Italian Lymphoma Foundation (FIL). Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). Leuk Lymphoma. 2015; 56(4): 921–926.
- Storti S, Spina M, Pesce EA, et al. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the . Haematologica. 2018; 103(8): 1345–1350.
- Marchesi F, Cenfra N, Altomare L, et al. A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment. J Geriatr Oncol. 2013; 4(3): 242–248.
- Bai JF, Han HX, Feng Ru, et al. Comprehensive Geriatric Assessment (CGA): a simple tool for guiding the treatment of older adults with diffuse large b-cell lymphoma in China. Oncologist. 2020; 25(8): e1202–e1208.
- Zhang H, Liu M, Li Q, et al. Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system. Leuk Lymphoma. 2022; 63(2): 353–361.
- Xu PP, Shi ZY, Qian Y, et al. Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study. Lancet Healthy Longev. 2022; 3(7): e481–e490.
- Ong DM, Ashby M, Grigg A, et al. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations. Br J Haematol. 2019; 187(1): 73–81.
- Chou WC, Chang H, Wang PN, et al. Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapy. Eur J Haematol. 2020; 105(4): 399–407.
- Isaksen KT, Mastroianni MA, Rinde M, et al. A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL. Blood Adv. 2021; 5(22): 4771–4782.
- Lastra-German IK, Navarrete-Reyes AP, Mejía-Domínguez NR, et al. Adjusted chemotherapy according to frailty status in elderly patients with diffuse large b-cell lymphoma: experience from a single referral center in mexico city. Clin Lymphoma Myeloma Leuk. 2019; 19(2): e98–e9e106.
- Vijenthira A, Mozessohn L, Nagamuthu C, et al. Frailty in patients with newly diagnosed diffuse large b-cell lymphoma receiving curative-intent therapy: a population-based study. J Natl Compr Canc Netw. 2022; 20(6): 635–642.e9.
- Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983; 31(12): 721–727.
- Graf C. The Lawton Instrumental Activities of Daily Living Scale. AJN, Am J Nurs. 2008; 108(4): 52–62.
- Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992; 41(3): 237–248.
- McIsaac DI, Wong CA, Huang A, et al. Derivation and validation of a generalizable preoperative frailty index using population-based health administrative data. Ann Surg. 2019; 270(1): 102–108.
- Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol. 2000; 35(3): 147–154.
- Droz JP, Balducci L, Bolla M, et al. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int. 2010; 106(4): 462–469.
- Droz JP, Aapro M, Balducci L, et al. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. Lancet Oncol. 2014; 15(9): e404–e414.
- Akhtar OS, Huang LW, Tsang M, et al. Geriatric assessment in older adults with non-Hodgkin lymphoma: a Young International Society of Geriatric Oncology (YSIOG) review paper. J Geriatr Oncol. 2022; 13(5): 572–581.
- Ferrat E, Audureau E, Paillaud E, et al. ELCAPA Study Group. Four distinct health profiles in older patients with cancer: latent class analysis of the prospective ELCAPA cohort. J Gerontol A Biol Sci Med Sci. 2016; 71(12): 1653–1660.
- Tucci A, Ferrari S, Bottelli C, et al. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer. 2009; 115(19): 4547–4553.
- Merli F, Luminari S, Tucci A, et al. The elderly project by the Fondazione Italiana Linfomi (FIL): a prospective multidimensional assessment of elderly patients with diffuse large b-cell lymphoma. Blood. 2016; 128(22): 3049–3049.
- Tavares A, Moreira I. Diffuse large B-cell lymphoma in very elderly patients: towards best tailored treatment - A systematic review. Crit Rev Oncol Hematol. 2021; 160: 103294.
- Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015; 26(6): 1091–1101.